DK1644493T3 - Regulering af en kinase, 'reguleret i COPD kinase' (RC-kinase) - Google Patents

Regulering af en kinase, 'reguleret i COPD kinase' (RC-kinase)

Info

Publication number
DK1644493T3
DK1644493T3 DK04739941.5T DK04739941T DK1644493T3 DK 1644493 T3 DK1644493 T3 DK 1644493T3 DK 04739941 T DK04739941 T DK 04739941T DK 1644493 T3 DK1644493 T3 DK 1644493T3
Authority
DK
Denmark
Prior art keywords
kinase
regulation
regulated
copd
reagents
Prior art date
Application number
DK04739941.5T
Other languages
English (en)
Inventor
Shinichi Watanabe
Jeffrey Encinas
Shinichi Kondo
Kevin Bacon
Original Assignee
Axikin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axikin Pharmaceuticals Inc filed Critical Axikin Pharmaceuticals Inc
Application granted granted Critical
Publication of DK1644493T3 publication Critical patent/DK1644493T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Plant Substances (AREA)
DK04739941.5T 2003-06-27 2004-06-16 Regulering af en kinase, 'reguleret i COPD kinase' (RC-kinase) DK1644493T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03014688 2003-06-27
EP04004818 2004-03-02
PCT/EP2004/006474 WO2005001083A1 (en) 2003-06-27 2004-06-16 Regulation of kinase, ´regulated in copd kinase´ (rc kinase)

Publications (1)

Publication Number Publication Date
DK1644493T3 true DK1644493T3 (da) 2010-09-13

Family

ID=33553805

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04739941.5T DK1644493T3 (da) 2003-06-27 2004-06-16 Regulering af en kinase, 'reguleret i COPD kinase' (RC-kinase)

Country Status (11)

Country Link
US (1) US7829685B2 (da)
EP (1) EP1644493B1 (da)
JP (2) JP4895808B2 (da)
AT (1) ATE470706T1 (da)
AU (1) AU2004251181B2 (da)
CA (1) CA2530663A1 (da)
DE (1) DE602004027632D1 (da)
DK (1) DK1644493T3 (da)
ES (1) ES2347247T3 (da)
PL (1) PL1644493T3 (da)
WO (1) WO2005001083A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1644493B1 (en) * 2003-06-27 2010-06-09 Axikin Pharmaceuticals, Inc. Regulation of a kinase, 'regulated in copd kinase' (rc kinase)
CA2718251A1 (en) * 2008-03-10 2009-09-17 Lineagen, Inc. Copd biomarker signatures
KR20140138293A (ko) 2012-03-16 2014-12-03 액시킨 파마수티컬스 인코포레이티드 3,5-다이아미노피라졸 키나아제 억제제
NZ631142A (en) 2013-09-18 2016-03-31 Axikin Pharmaceuticals Inc Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
US9546163B2 (en) 2014-12-23 2017-01-17 Axikin Pharmaceuticals, Inc. 3,5-diaminopyrazole kinase inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ241311A (en) 1991-01-17 1995-03-28 Gen Hospital Corp Rna sequence having trans-splicing activity, plant strains
WO1993003151A1 (en) 1991-08-10 1993-02-18 Medical Research Council Treatment of cell populations
ATE199392T1 (de) 1992-12-04 2001-03-15 Medical Res Council Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung
US5705151A (en) 1995-05-18 1998-01-06 National Jewish Center For Immunology & Respiratory Medicine Gene therapy for T cell regulation
JP2004537258A (ja) 2000-10-20 2004-12-16 インサイト・ゲノミックス・インコーポレイテッド ヒトキナーゼ
US6582946B1 (en) * 2001-03-12 2003-06-24 Applera Corporation Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
CA2440575A1 (en) * 2001-05-07 2002-11-14 Marion Webster Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2003018786A2 (en) 2001-08-20 2003-03-06 Bayer Healthcare Ag Human serine/threonine kinase
EP1644493B1 (en) 2003-06-27 2010-06-09 Axikin Pharmaceuticals, Inc. Regulation of a kinase, 'regulated in copd kinase' (rc kinase)

Also Published As

Publication number Publication date
JP4895808B2 (ja) 2012-03-14
DE602004027632D1 (de) 2010-07-22
EP1644493B1 (en) 2010-06-09
ATE470706T1 (de) 2010-06-15
ES2347247T3 (es) 2010-10-27
JP2011234724A (ja) 2011-11-24
US20080261903A1 (en) 2008-10-23
AU2004251181A1 (en) 2005-01-06
HK1095355A1 (en) 2007-05-04
EP1644493A1 (en) 2006-04-12
CA2530663A1 (en) 2005-01-06
AU2004251181B2 (en) 2009-10-01
WO2005001083A1 (en) 2005-01-06
US7829685B2 (en) 2010-11-09
JP2007527209A (ja) 2007-09-27
PL1644493T3 (pl) 2010-11-30

Similar Documents

Publication Publication Date Title
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
ATE450530T1 (de) Zusammensetzungen zur verwendung als protein- kinase-inhibitoren
DE602005020611D1 (de) Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
ATE362928T1 (de) 2-(1h-indazol-6-ylamino)- benzamid-verbindungen als protein kinase inhibitoren und deren verwendung zur behandlung von ophthalmischen krankheiten
ATE482213T1 (de) Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine
DE60332433D1 (de) Azolylaminoazine als proteinkinasehemmer
DE60332604D1 (de) Azolylaminoazine als proteinkinasehemmer
DE60234453D1 (de) Substituierte piperazin- und diazepanderivate zur verwendung als histamin h3 rezeptormodulatoren
BRPI0407446A (pt) Anticorpos para c-met para o tratamento de cânceres
WO2005112981A3 (en) Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells
NO20064976L (no) Azanidoler som er nyttige som inhibitorer av rock og andre proteinkinaser
CY1111590T1 (el) Αρυλ και ετεροαρυλ ουριας αναστολεις chk1 για χρηση ως ραδιοευαισθοποιητες και χημειοευαισθητοποιητες
NO20092741L (no) DR6-antagonister og anvendelse derav ved behandling av neurologiske forstyrrelser
NO341523B1 (no) Benzoimidazol-2-ylpyrimidiner og -pyraziner som modulatorer av histamin H4-reseptoren, farmasøytisk sammensetning samt anvendelse
HRP20050318A2 (en) Pyrimidinone derivatives as therapeutic agents against acute and chronic inflamatory, ischaemic and remodelling processes
MX2009009146A (es) Metodos y objetivos para identificar compuestos para regular la infeccion por rinovirus.
AU2003263552A8 (en) Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
NO20082026L (no) Deazapuriner som er nyttige som inhibitorer for Janus-kinaser
BRPI0512974A (pt) novos derivados de hidantoìna para o tratamento de doenças obstrutivas das vias aéreas
DK1644493T3 (da) Regulering af en kinase, 'reguleret i COPD kinase' (RC-kinase)
WO2002028906A3 (en) Regulation of human sphingosine kinase-like protein
NO20020130L (no) Anvendelse av FVIIa eller en vevsfaktorantagonist til regulering av genekspresjon og cellemigrasjon eller kjemotaksis
WO2001090160A3 (en) REGULATION OF HUMAN p78-LIKE SERINE/THREONINE KINASE
WO2004013311A3 (en) Compositions and methods relating to ovarian specific genes and proteins